Archived Press Releases

May 31, 2024

Verve Therapeutics Announces Leadership Update

May 31, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 30, 2024

Verve Therapeutics to Participate in Upcoming Investor Conferences

May 08, 2024

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

May 07, 2024

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

May 03, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apr 02, 2024

Verve Therapeutics Announces Updates on its PCSK9 Program

Mar 28, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Mar 01, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)